Recombinant adenoviral vectors can induce expression of p73 via the E4-orf6/7 protein

被引:7
|
作者
Shapiro, Gary S.
Van Peursem, Crystal
Ornelles, David A.
Schaack, Jerome
DeGregori, James
机构
[1] Univ Colorado, Dept Biochem & Mol Genet, Dept Pediat, Integrated Dept Immunol,Program Mol Biol, Aurora, CO 80045 USA
[2] Ctr Hlth Sci, Aurora, CO 80045 USA
[3] Wake Forest Univ, Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA
[4] Univ Colorado, Dept Microbiol, Program Mol Biol, Aurora, CO 80045 USA
关键词
D O I
10.1128/JVI.02016-05
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Despite the utility of recombinant adenoviral vectors in basic research, their therapeutic promise remains unfulfilled. Most engineered adenoviral vectors use a heterologous promoter to transcribe a foreign gene. We show that adenoviruses containing the cytomegalovirus immediate-early promoter induce the expression of the proapoptotic cellular protein TAp73 via the cyclin-dependent kinase-retinoblastoma protein-E2F pathway in murine embryonic fibroblasts. Cells transduced with these vectors also expressed high levels of the adenoviral E4-orf6/7 and E2A proteins. By contrast, adenoviruses containing the ubiquitin C promoter failed to elicit these effects. E4-orf6/7 is necessary and sufficient for increased TAp73 expression, as shown by using retrovirus-mediated E4-orf6/7 expression and adenovirus with the E4-orf6/7 gene deleted. Activation of TAp73 likely occurs via E4-orf6/7-induced dimerization of E2F and subsequent binding to the inverted E2F-responsive elements within the TAp73 promoter. In addition, adenoviral vectors containing the cytomegalovirus immediate-early promoter, but not the ubiquitin C promoter, cooperated with chemotherapeutic agents to decrease cellularity in vitro. In contrast to murine embryonic fibroblasts, adenoviruses containing the ubiquitin C promoter, but not the cytomegalovirus immediate-early promoter, induced both E4-orf6/7 and TAp73 in human foreskin fibroblasts, emphasizing the importance of cellular context for promoter-dependent effects. Because TAp73 is important for the efficacy of chemotherapy, adenoviruses that increase TAp73 expression may enhance cancer therapies by promoting apoptosis. However, such adenoviruses may impair the long-term survival of transduced cells during gene replacement therapies. Our findings reveal previously unknown effects of foreign promoters in recombinant adenoviral vectors and suggest means to improve the utility of engineered adenoviruses by better controlling their impact on viral and cellular gene expression.
引用
收藏
页码:5349 / 5360
页数:12
相关论文
共 50 条
  • [41] HPV E6/E7 oncoprotein promotes cervical cancer by promoting miR-466 expression via P53 pathway
    Shen, Y.
    Xu, Q-X.
    ANNALS OF ONCOLOGY, 2018, 29 : 83 - 83
  • [42] Cdc55p-mediated E4orf4 growth inhibition in Saccharomyces cerevisiae is mediated only in part via the catalytic subunit of protein phosphatase 2A
    Li, Yikun
    Wei, Huijun
    Hsieh, Tung-Chin
    Pallas, David C.
    JOURNAL OF VIROLOGY, 2008, 82 (07) : 3612 - 3623
  • [43] A functional complex of adenovirus proteins E1B-55kDa and E4orf6 is necessary to modulate the expression level of p53 but not its transcriptional activity
    Cathomen, T
    Weitzman, MD
    JOURNAL OF VIROLOGY, 2000, 74 (23) : 11407 - 11412
  • [44] Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway
    Wang, Xiaohong
    Meyers, Craig
    Guo, Ming
    Zheng, Zhi-Ming
    INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (06) : 1362 - 1372
  • [45] Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism, involving a Cullin-containing complex
    Querido, E
    Blanchette, P
    Yan, Q
    Kamura, T
    Morrison, M
    Boivin, D
    Kaelin, WG
    Conaway, RC
    Conaway, JW
    Branton, PE
    GENES & DEVELOPMENT, 2001, 15 (23) : 3104 - 3117
  • [46] Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with β3 integrin
    Cui, Xiaoyun
    Wu, Yanhua
    Fan, Dongying
    Gao, Na
    Ming, Ying
    Wang, Peigang
    An, Jing
    ANTIVIRAL RESEARCH, 2018, 155 : 20 - 27
  • [47] Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53
    DasGupta, Twishasri
    Nweze, Emeka I.
    Yue, Hong
    Wang, Liming
    Jin, Jessica
    Ghosh, Santosh K.
    Kawsar, Hameem I.
    Zender, Chad
    Androphy, Elliot J.
    Weinberg, Aaron
    McCormick, Thomas S.
    Jin, Ge
    ONCOTARGET, 2016, 7 (19) : 27430 - 27444
  • [48] Expression of human papilloma virus E7 protein causes apoptosis and inhibits DNA synthesis in primary hepatocytes via increased expression of p21Cip-1/WAF1/MDA6
    Park, JS
    Boyer, S
    Mitchell, K
    Gilfor, D
    Birrer, M
    Darlington, G
    El Deiry, W
    Firestone, GL
    Munger, K
    Band, V
    Fisher, PB
    Dent, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (01) : 18 - 28
  • [49] The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2
    Friedrich Krätzer
    Olaf Rosorius
    Peter Heger
    Nicole Hirschmann
    Thomas Dobner
    Joachim Hauber
    Roland H Stauber
    Oncogene, 2000, 19 : 850 - 857
  • [50] The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2
    Krätzer, F
    Rosorius, O
    Heger, P
    Hirschmann, N
    Dobner, T
    Hauber, J
    Stauber, RH
    ONCOGENE, 2000, 19 (07) : 850 - 857